Orphan drugs for the pathogenetic treatment of rаre diseases in the drug registry
https://doi.org/10.24411/25880519-2018-10058
Abstract
Introduction. Despite the high cost of life-threatening rаre diseases, not all expensive drugs for the pathogenetic treatment of orphan diseases are included in the list of vital and essential drugs. Aim. Analysis of drugs for pathogenetic treatment of diseases included in the orphan drugs lists, in order to determine the specific names not included in the list of vital and essential drugs (VET List) for medical use in 2019. Materials and methods. From the standards of medical care for rare diseases included in the Decree of the Government of the Russian Federation of April 26, 2012 № 403 and the order of the government of the Russian Federation of December 10, 2018 № 2738-p allocated 62 international non-patented names of drugs. The data obtained from the relevant INN in the State register of drugs of the Russian Ministry of health of was analyzed. Results. 90 % of the drugs are reference, 34 % interchangeable, 81 % of the considered included in the VET List for 2019. The remaining 19 % is not necessary and therefore does not have a registered selling price. Summary. Analysis of orphan drug lists revealed the absence of some of the expensive drugs in the VET List, which makes it impossible to control the maximum selling prices of the manufacturer by the government.
About the Author
S. A. Mishinova
I.P. Pavlov First SPbSMU MOH Russia
Russian Federation
Russian Federation
Mishinova Sofya - Post-graduate student, Department of Clinical Pharmacology and Evidence-Based Medicine.
References
1. Order of the ministry of health and social development of the Russian Federation №159 of 9 March 2007. «O merakh po obespecheniyu otdel’nykh kategorii grazhdan neobkhodimymi lekarstvennymi sredstvami». (In Russ). Дост упно по: http://www.garant.ru/products/ipo/prime/doc/4084448. Ссылка активна на 10.01.2019.
2. Federal Law of the Russian Federation №132-FZ of 17 July 2007.«O vnesenii izmenenii v Federal’nyi zakon «O federal’nom byudzhete na 2007 god». (In Russ). Доступно по: http://www.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=53437#04642988066871476. Ссылка активна на 10.01.2019.
3. Federal Law №229-FZ of 3 August 2018 «O vnesenii izmenenii v federal’nyi zakon «Ob osnovakh okhrany zdorov’ya grazhdan v Rossiiskoi Federatsii». (In Russ). Доступно по: http://base.garant.ru/72005588/. Ссылка активна на 10.01.2019.
4. Federal Law of the Russian Federation №61-FZ of 12 April 2010 «Ob obrashchenii lekarstvennykh sredstv». (In Russ). Доступно по: http://www.consultant.ru/document/cons_doc_LAW_99350/. Ссылка активна на 10.01.2019.
5. Federal Law of Russian Federation №323-F3 of 21 November 2011. «Ob osnovakh okhrany zdorov’ya grazhdan Rossiiskoi Federatsii». (In Russ). Доступно по: http://www.consultant.ru/document/cons_doc_LAW_121895/. Ссылка активна на 10.01.2019.
6. Order of the Ministry of Health of Russia № 930n of 12/15/2015. «Ob utverzhdenii ob»ema informatsii, neobkhodimogo dlya formirovaniya razdela klinicheskoi dokumentatsii, pri gosudarstvennoi registratsii orfannogo lekarstvennogo preparata». (In Russ). Доступно по: http://ivo.garant.ru/#/document/71356638/paragraph/1:1. Ссылка активна на 10.01.2019.
7. Decree of the Government of the Russian Federation № 2738-r of 10 December 2018. «Ob utverzhdenii perechnya zhiznenno neobkhodimykh i vazhneishikh lekarstvennykh preparatov na 2019 god, a takzhe perechnei lekarstvennykh preparatov dlya meditsinskogo primeneniya i minimal’nogo assortimenta lekarstvennykh preparatov, neobkhodimykh dlya okazaniya meditsinskoi pomoshchii». (In Russ). Доступно по: http://ivo.garant.ru/#/document/72123048/paragraph/7:3. Ссылка активна на 10.01.2019.
8. Resolution of the Government of the Russian Federation №403 of 26 April 2012. «O poryadke vedeniya Federal’nogo registra lits, stradayushchikh zhizneugrozhayushchimi i khronicheskimi progressiruyushchimi redkimi (orfannymi) zabolevaniyami, privodyashchimi k sokrashcheniyu prodolzhitel’nosti zhizni grazhdan ili ikh invalidnosti, i ego regional’nogo segmenta». (In Russ). Доступно по: http://base.garant.ru/70168888/#friends. Ссылка активна на 10.01.2019.
9. mkb-10.com [интернет]. Международная классификация болезней 10-го пересмотра (МКБ-10) [доступ от 10.01.2019]. Доступ по ссылке http://mkb-10.com/index.php?pid=3256.
10. rosminzdrav.ru [интернет]. Перечень редких (орфанных) заболеваний от 24.05.2018 [доступ от 10.01.2019]. Доступ по ссылке: https://www.rosminzdrav.ru/documents/8048-perechen-redkih-orfannyh-zabolevaniy.
11. Letter of the Ministry of Health of Russia № 13-2/10/2-3113 of 30 April 2013. Доступно по: https://www.rosminzdrav.ru/documents/5521-pismo-minzdrava-rossii-ot-30-aprelya-2013-g-13-2-10-2-3113. Ссылка активна на 10.01.2019.
12. Balashov A.I. Formirovanie mekhanizma ustoichivogo razvitiya farmatsevticheskoi otrasli: teoriya i metodologiya. St. Petersburg: Publishing House of St. Petersburg State University of Economics and Finance; 2012. (In Russ).
13. zakupki.gov.ru [интернет]. Единая информационная система в сфере закупок [доступ от: 10.01.2019]. Доступ по ссылке http://www.zakupki.gov.ru/epz/main/public/home.html
Review
For citations:
Mishinova S.A. Orphan drugs for the pathogenetic treatment of rаre diseases in the drug registry. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2018;(4):44-52. (In Russ.) https://doi.org/10.24411/25880519-2018-10058
Views:
1426
Email this article 